Delta-Fly Pharma, Inc.

Notice Regarding Monthly Exercise Status of the 12th Series Stock Acquisition Rights Issued by Third-Party Allocation (with Exercise Price Adjustment Clause)

Monthly exercise status of stock acquisition rights disclosed. Exercises during the target month totaled 45,060 units (45.06% of the total issued 100,000 units), transferred treasury shares amounted to 5,020,000 shares, the number of listed shares at the time of payment...

Notice of Large-Scale Exercise of the 12th Stock Acquisition Rights Issued Through Third-Party Allotment (Exercise Price Revision Clause)

Since the previous disclosure, the number of issued stock acquisition rights issued is 3,026,000 shares, with an exercise ratio of 30.26%; unexercised rights total 50,700 units (5,070,000 shares) remaining, a reduction from 80,960 units (8,096,000 shares) at the previous disclosure....

Notice on the Monthly Exercise Status of the 12th Stock Acquisition Right Issued Through Third-Party Allotment (With Exercise Price Adjustment Clause)

Notice on Monthly Exercise Status of the 12th Series of Stock Acquisition Rights Issued through a Third-Party Allotment (With Exercise Price Adjustment Clause)

Notice on the Data Analysis Status of the Phase 2 Part of the Phase 2/3 Trial of DFP-17729